Schonfeld Strategic Advisors’s Insight Molecular Diagnostics Inc. Common Stock IMDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-985
| Closed | -$4.53K | – | 1955 |
|
|
2023
Q2 | $4.53K | Sell |
985
-90
| -8% | -$414 | ﹤0.01% | 1800 |
|
|
2023
Q1 | $7.62K | Sell |
1,075
-20,120
| -95% | -$143K | ﹤0.01% | 1798 |
|
|
2022
Q4 | $136K | Sell |
21,195
-16,290
| -43% | -$105K | ﹤0.01% | 2074 |
|
|
2022
Q3 | $547K | Sell |
37,485
-10,385
| -22% | -$152K | ﹤0.01% | 1662 |
|
|
2022
Q2 | $862K | Sell |
47,870
-2,665
| -5% | -$48K | 0.01% | 1014 |
|
|
2022
Q1 | $1.51M | Sell |
50,535
-1,040
| -2% | -$31K | 0.01% | 785 |
|
|
2021
Q4 | $2.24M | Sell |
51,575
-11,973
| -19% | -$520K | 0.02% | 618 |
|
|
2021
Q3 | $4.52M | Sell |
63,548
-5,902
| -8% | -$420K | 0.05% | 425 |
|
|
2021
Q2 | $7.97M | Sell |
69,450
-11,691
| -14% | -$1.34M | 0.08% | 322 |
|
|
2021
Q1 | $8.42M | Buy |
81,141
+74,771
| +1,174% | +$7.76M | 0.1% | 247 |
|
|
2020
Q4 | $304K | Buy |
+6,370
| New | +$304K | ﹤0.01% | 1164 |
|
|
2019
Q3 | – | Sell |
-9,525
| Closed | -$474K | – | 1157 |
|
|
2019
Q2 | $474K | Sell |
9,525
-33,915
| -78% | -$1.69M | 0.02% | 649 |
|
|
2019
Q1 | $3.43M | Buy |
+43,440
| New | +$3.43M | 0.12% | 231 |
|